Bioavailability and Bioequivalence


Bioavailability is defined as amount of drug available to the target site after systemic circulation and Bioequivalence is the similarity of two drugs must release the active ingredient at the same amount, rate &quality. In this process the new drugs are tested for their stability studies. The new formulations undergo the analytical process to get approved by the FDA as a safe and effective dosage form. It is frequent to compare new drug with the standard product as a reference.

  1. In vivo & In vitro drug studies
  2. Accelerated stability studies
  3. Chromatography types and techniques
  4. HPLC to monitor β-lactam plasma
  5. Chemically, therapeutically and physically bioequivalent.
  6. Cationic prodrugs as dual gene reagents

    Related Conference of Bioavailability and Bioequivalence

    August 18-19, 2025

    40th World Congress on Pharmacology and Therapeutics

    Valencia, Spain
    August 27-28, 2025

    20th World Congress on Drug Formulation & Drug Delivery

    Amsterdam, Netherlands
    September 19-20, 2025

    18th World Drug Delivery Summit

    Paris, France
    September 22-23, 2025

    Pharma Biotech Expo

    Toronto, Canada
    September 23-24, 2025

    10th International Conference on Future Pharma and Innovations

    Amsterdam, Netherlands
    September 24-25, 2025

    5th World Congress on Rare Diseases & Orphan Drugs

    Aix-en-Provence, France
    October 23-24, 2025

    21st Annual Meet on Pharmaceutical Sciences

    Aix-en-Provence, France
    November 11-12, 2025

    6th Annual Congress on Antibiotics and Bacterial Infections

    Amsterdam, Netherlands
    November 13-14, 2025

    21st International Conference on Pharmaceutical Chemistry

    Aix-en-Provence, France
    November 20-21, 2025

    21st Annual Congress on Pharmacology and Toxicology

    Paris, France
    November 27-28, 2025

    4th World Congress on Precision and Personalized Medicine

    Zurich, Switzerland
    November 27-28, 2025

    4th World Conference on Pharma Industry and Medical Devices

    Zurich, Switzerland
    December 01-02, 2025

    13th International Conference on Clinical Trials

    Vancouver, Canada
    February 23-24, 2026

    3rd World Congress on Biologics and Biosimilars

    London, Aland Islands
    April 27-28, 2026

    9th European Biopharma Congress

    Paris, Aland Islands
    May 21-22, 2026

    8th International Conference and Exhibition on Pain Management

    Aix-en-Provence, France

    Bioavailability and Bioequivalence Conference Speakers

      Recommended Sessions

      Related Journals

      Are you interested in